Dehaier Medical Systems Limited provided earnings guidance for the year ended December 31, 2014. For the year, the company expects to report revenues of approximately $12 million, representing a year-over-year decrease of approximately 29%. This decrease was mainly due to lower sales from the company medical device distribution business.

Operating loss of approximately $1.8 million for the year ended December 31, 2014, compared to operating income of $3.5 million for the year ended December 31, 2013 as a result of decrease in gross margin and increase in SG&A expenses which were primarily attributable to amortization of employees and consultants share-based compensation expenses. On a non-GAAP basis after adjusting for $2.6 million, adjusted operating income is expected to be approximately $0.8 million for the year ended December 31, 2014, compared to $4.9 million for the year ended December 31, 2013. net income attributable to Dehaier of approximately $1.3 million, or $0.23 per diluted share, for the year ended December 31, 2014, compared to $2.0 million, or $0.43 per diluted share, for the year ended December 31, 2013.